Page last updated: 2024-09-03

ginsenoside rh2 and Experimental Neoplasms

ginsenoside rh2 has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HF; Chen, QC; Li, W; Lin, T; Liu, WC; Wei, GQ; Zeng, JZ; Zhang, WY; Zhang, XK; Zheng, YN1
Liu, FG; Zhang, WY; Zheng, YN1
Bu, X; Bush, JA; Chen, X; Jia, WW; Li, G; Liu, G; Philips, D; Yan, H1

Other Studies

3 other study(ies) available for ginsenoside rh2 and Experimental Neoplasms

ArticleYear
Structural modification of ginsenoside Rh(2) by fatty acid esterification and its detoxification property in antitumor.
    Bioorganic & medicinal chemistry letters, 2012, Jan-15, Volume: 22, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Esters; Fatty Acids; Ginsenosides; Humans; Mice; Mice, Inbred Strains; Molecular Conformation; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Spleen; Structure-Activity Relationship; Thymus Gland; Xenograft Model Antitumor Assays

2012
[Synthesis and anti-tumor activity of ginsenoside Rh_2 caprylic acid monoester].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2019, Volume: 44, Issue:17

    Topics: Animals; Caprylates; Ginsenosides; Mice; Molecular Structure; Neoplasms, Experimental; Saponins

2019
Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.
    Canadian journal of physiology and pharmacology, 2004, Volume: 82, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ginsenosides; Humans; Mice; Mice, Inbred C57BL; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Panax; Plant Extracts; Receptors, Glucocorticoid; Tumor Suppressor Protein p53

2004